Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes

Farngren, J; Ahren, B

Ahren, B (reprint author), Lund Univ, Dept Clin Sci Lund, BMC C11,Solvegatan 19, S-22184 Lund, Sweden.

METABOLISM-CLINICAL AND EXPERIMENTAL, 2019; 99 (): 25

Abstract

Hypoglycaemia is common in both type 1 and type 2 diabetes and has both acute and long-term consequences. Therefore, a key to proper glucose-lowering ......

Full Text Link